Baidu
map

18种药品由处方药转换为非处方药

2018-05-10 吴施楠 搜狐健康

日前,国家药品监督管理局发布公告,对19种药品的管理类别进行了重新界定。公告指出,根据《处方药与非处方药分类管理办法(试行)》(国家药品监督管理局令第10号)的规定,经国家药品监督管理局组织论证和审定,板蓝根泡腾片等18种药品由处方药转换为非处方药;伤湿止痛膏已不符合目前乙类非处方药确定原则,由乙类非处方药转换为甲类非处方药。其他调整的药品品种见文末表格。我国现行《药品管理法》对药品按照处方药、O

日前,国家药品监督管理局发布公告,对19种药品的管理类别进行了重新界定。

公告指出,根据《处方药与非处方药分类管理办法(试行)》(国家药品监督管理局令第10号)的规定,经国家药品监督管理局组织论证和审定,板蓝根泡腾片等18种药品由处方药转换为非处方药;伤湿止痛膏已不符合目前乙类非处方药确定原则,由乙类非处方药转换为甲类非处方药。其他调整的药品品种见文末表格。

我国现行《药品管理法》对药品按照处方药、OTC(非处方药)甲类、乙类分类管理。

处方药是指必须凭执业医师或执业助理医师处方才可调配、购买和使用药品;非处方药是指为方便公众用药,在保证用药安全的前提下,经国家卫生行政部门规定或审定后,不需要医师或其它医疗专业人员开写处方即可购买的药品,一般公众凭自我判断,按照药品标签及使用说明就可自行使用。

一种药品从处方药转为非处方药,需要长期的临床数据积累,证明该药品在非处方药销售模式下不会出现过量使用、不当使用、或因人体差异而出现的安全性问题。

在此之前,国家药品监督管理局每年都会批准一定数量的处方药转为非处方药。由于药品特殊性,国际上对处方药转为非处方药始终比较慎重。此次公布的19个品种,也以中成药居多。

在销售方面,处方药只能凭医生处方销售,绝大部分市场局限在医院终端,且不得在大众媒体进行广告宣传。前不久,引发舆论风波的“鸿茅药酒”,正在国家药品监督管理局的组织下,进行由非处方药转化为处方药进行论证工作。如果一旦转成处方药,鸿茅药酒就不能再像之前那样,发布铺天盖地的广告进行宣传了。

此外,《处方药与非处方药分类管理办法(试行)》中还规定,经营处方药、甲类非处方药的药品零售企业应当配备执业药师或者其他依法经资格认定的药学技术人员。经营乙类非处方药的药品销售企业,应当配备经设区的市级食品药品监督管理机构或者省、自治区、直辖市人民政府食品药品监督管理部门直接设置的县级食品药品监督管理机构组织考核合格的业务人员。

从处方药变成非处方药,意味着这些药品到患者手中的会渠道增加,更加容易被买到。但值得注意的是,有数据显示,我国每年因药物不良反应住院的病人达250万,每年约有19.2万人死于药物不良反应。因此,虽然是非处方药,但在购买和使用时,也要引起充分重视。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1819208, encodeId=2e0b18192088f, content=<a href='/topic/show?id=0805993615a' target=_blank style='color:#2F92EE;'>#非处方#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99361, encryptionId=0805993615a, topicName=非处方)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f98e185, createdName=psybestwish, createdTime=Fri Nov 16 00:14:00 CST 2018, time=2018-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314327, encodeId=88a231432ebd, content=学习., beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDcVAydhtcpjiaxLrZD7Eb5YnKPgf7ypGpfyl7FflFyAenvQLbib6T0LPXIhXo9SPNPXYYFFJbEgykztwJ0HQ61I3F9GxIVKWsgQ/0, createdBy=f38d2052407, createdName=周周人, createdTime=Sat May 12 06:50:06 CST 2018, time=2018-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1589654, encodeId=99561589654f5, content=<a href='/topic/show?id=10f299362a1' target=_blank style='color:#2F92EE;'>#非处方药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99362, encryptionId=10f299362a1, topicName=非处方药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=716117772264, createdName=gracezdd, createdTime=Sat May 12 03:14:00 CST 2018, time=2018-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=313832, encodeId=a963313832b8, content=了解一下.谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Thu May 10 13:51:17 CST 2018, time=2018-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=313811, encodeId=ed3f313811d2, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Thu May 10 12:59:23 CST 2018, time=2018-05-10, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1819208, encodeId=2e0b18192088f, content=<a href='/topic/show?id=0805993615a' target=_blank style='color:#2F92EE;'>#非处方#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99361, encryptionId=0805993615a, topicName=非处方)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f98e185, createdName=psybestwish, createdTime=Fri Nov 16 00:14:00 CST 2018, time=2018-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314327, encodeId=88a231432ebd, content=学习., beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDcVAydhtcpjiaxLrZD7Eb5YnKPgf7ypGpfyl7FflFyAenvQLbib6T0LPXIhXo9SPNPXYYFFJbEgykztwJ0HQ61I3F9GxIVKWsgQ/0, createdBy=f38d2052407, createdName=周周人, createdTime=Sat May 12 06:50:06 CST 2018, time=2018-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1589654, encodeId=99561589654f5, content=<a href='/topic/show?id=10f299362a1' target=_blank style='color:#2F92EE;'>#非处方药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99362, encryptionId=10f299362a1, topicName=非处方药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=716117772264, createdName=gracezdd, createdTime=Sat May 12 03:14:00 CST 2018, time=2018-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=313832, encodeId=a963313832b8, content=了解一下.谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Thu May 10 13:51:17 CST 2018, time=2018-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=313811, encodeId=ed3f313811d2, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Thu May 10 12:59:23 CST 2018, time=2018-05-10, status=1, ipAttribution=)]
    2018-05-12 周周人

    学习.

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1819208, encodeId=2e0b18192088f, content=<a href='/topic/show?id=0805993615a' target=_blank style='color:#2F92EE;'>#非处方#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99361, encryptionId=0805993615a, topicName=非处方)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f98e185, createdName=psybestwish, createdTime=Fri Nov 16 00:14:00 CST 2018, time=2018-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314327, encodeId=88a231432ebd, content=学习., beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDcVAydhtcpjiaxLrZD7Eb5YnKPgf7ypGpfyl7FflFyAenvQLbib6T0LPXIhXo9SPNPXYYFFJbEgykztwJ0HQ61I3F9GxIVKWsgQ/0, createdBy=f38d2052407, createdName=周周人, createdTime=Sat May 12 06:50:06 CST 2018, time=2018-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1589654, encodeId=99561589654f5, content=<a href='/topic/show?id=10f299362a1' target=_blank style='color:#2F92EE;'>#非处方药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99362, encryptionId=10f299362a1, topicName=非处方药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=716117772264, createdName=gracezdd, createdTime=Sat May 12 03:14:00 CST 2018, time=2018-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=313832, encodeId=a963313832b8, content=了解一下.谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Thu May 10 13:51:17 CST 2018, time=2018-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=313811, encodeId=ed3f313811d2, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Thu May 10 12:59:23 CST 2018, time=2018-05-10, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1819208, encodeId=2e0b18192088f, content=<a href='/topic/show?id=0805993615a' target=_blank style='color:#2F92EE;'>#非处方#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99361, encryptionId=0805993615a, topicName=非处方)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f98e185, createdName=psybestwish, createdTime=Fri Nov 16 00:14:00 CST 2018, time=2018-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314327, encodeId=88a231432ebd, content=学习., beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDcVAydhtcpjiaxLrZD7Eb5YnKPgf7ypGpfyl7FflFyAenvQLbib6T0LPXIhXo9SPNPXYYFFJbEgykztwJ0HQ61I3F9GxIVKWsgQ/0, createdBy=f38d2052407, createdName=周周人, createdTime=Sat May 12 06:50:06 CST 2018, time=2018-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1589654, encodeId=99561589654f5, content=<a href='/topic/show?id=10f299362a1' target=_blank style='color:#2F92EE;'>#非处方药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99362, encryptionId=10f299362a1, topicName=非处方药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=716117772264, createdName=gracezdd, createdTime=Sat May 12 03:14:00 CST 2018, time=2018-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=313832, encodeId=a963313832b8, content=了解一下.谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Thu May 10 13:51:17 CST 2018, time=2018-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=313811, encodeId=ed3f313811d2, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Thu May 10 12:59:23 CST 2018, time=2018-05-10, status=1, ipAttribution=)]
    2018-05-10 天地飞扬

    了解一下.谢谢分享!

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1819208, encodeId=2e0b18192088f, content=<a href='/topic/show?id=0805993615a' target=_blank style='color:#2F92EE;'>#非处方#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99361, encryptionId=0805993615a, topicName=非处方)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f98e185, createdName=psybestwish, createdTime=Fri Nov 16 00:14:00 CST 2018, time=2018-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314327, encodeId=88a231432ebd, content=学习., beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDcVAydhtcpjiaxLrZD7Eb5YnKPgf7ypGpfyl7FflFyAenvQLbib6T0LPXIhXo9SPNPXYYFFJbEgykztwJ0HQ61I3F9GxIVKWsgQ/0, createdBy=f38d2052407, createdName=周周人, createdTime=Sat May 12 06:50:06 CST 2018, time=2018-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1589654, encodeId=99561589654f5, content=<a href='/topic/show?id=10f299362a1' target=_blank style='color:#2F92EE;'>#非处方药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99362, encryptionId=10f299362a1, topicName=非处方药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=716117772264, createdName=gracezdd, createdTime=Sat May 12 03:14:00 CST 2018, time=2018-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=313832, encodeId=a963313832b8, content=了解一下.谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Thu May 10 13:51:17 CST 2018, time=2018-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=313811, encodeId=ed3f313811d2, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Thu May 10 12:59:23 CST 2018, time=2018-05-10, status=1, ipAttribution=)]
    2018-05-10 虈亣靌

    学习了受益匪浅

    0

相关资讯

国家药品监督管理局发文:板蓝根泡腾片等18种药品由处方药转换为非处方药

5月8日,国家药品监督管理局发布《关于调整板蓝根泡腾片等19个品种管理类别的公告(2018年第16号)》。根据《处方药与非处方药分类管理办法(试行)》(国家药品监督管理局令第10号)的规定,经国家药品监督管理局组织论证和审定,板蓝根泡腾片等18种药品由处方药转换为非处方药;伤湿止痛膏已不符合目前乙类非处方药确定原则,由乙类非处方药转换为甲类非处方药。

病例分享:27岁男青年服用感冒药仅7天5个脏器系统衰竭而丧命!非处方药带来的致命风险防不胜防?

当我坐在办公桌前写下此文时,故事的主人公:一位27岁的男青年刚刚因多脏器衰竭离开人世,从入院到去世仅7天,两家三甲医院,数十名医护人员,动用了最先进的抢救措施和设备,但依然没能挽救他的生命。逝者已矣,但他留给我们的教训却是值得记述、并应该让更多人知道的。

刚刚!总局宣布修订跌打万花油等32种非处方药说明书

刚刚,国家食品药品监督管理总局发布了一则公告,将修订跌打万花油等多打32种非处方药的说明书。

自动售药机可售非处方药

一则迟到的新闻,对药品零售行业来讲却尤为重要。有人将其看作是打开了药品零售又一接地气的实用新渠道。 自动售药机,可售甲类非处方药,可离店

CFDA公告四产品修改说明 有产品被禁网售

为保障公众用药安全,根据《处方药与非处方药分类管理办法(试行)》(原国家药品监督管理局令第10号)的规定,经国家食品药品监督管理总局组织论证和审定,将精乌胶囊调出非处方药目录,按处方药管理,百乐眠胶囊由乙类非处方药调整为甲类非处方药,同时对上述2种药品及七宝美髯丸、心元胶囊的说明书进行修订。

Int J Clin Pharm:孕期过分谨慎用药反而对有害于胎儿的健康

近日,来自东安格利亚大学药学院的一项新的研究发现,孕妇对处方和非处方药的使用过于谨慎。研究共纳入了1120名女性,对于妊娠常见症状如恶心、泌尿道感染和疼痛,很多参与者并不愿意接受治疗。通过在线调查收集参与者孕期所发生的常见症状的数据。询问参与者药物治疗这些症状有害还是有益以及是否有意避免孕期使用药物,如果是继续询问是哪些药物。结果发现,约四分之三的参与者(76.4 %)的妇女服用过处方或非处方药。

Baidu
map
Baidu
map
Baidu
map